
Opinion|Videos|May 15, 2024
FDA-approved Therapies for Geographic Atrophy
An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
ONL Therapeutics randomizes first European patient in phase 2 GA trial of Xelafaslatide
2
Ophthalmic drug shortages more frequent, longer lasting than average
3
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
4



































